$加科思-B(01167.HK)$strange things happening.. despite announcing drug approvals, the share price keeps going down. Does the company fail to perform ? unable to fulfill the promises made to its investors ??
Despite the recent losses, insiders' purchases suggest a bullish sentiment towards the company. The high level of insider ownership indicates a reasonable degree of alignment with common shareholders, which is seen as a positive sign for the company's future.
加科思-B股票讨论区
暂无评论